Peptide vaccine candidate mimics the heterogeneity of natural SARS-CoV-2 immunity in convalescent humans and induces broad T cell responses in mice models
E. Somogyi, Z. Csiszovszki, L. Molnar, O. Lorincz, J. Toth, S. Pattijn, J. Schockaert, A. Mazy, I. Miklos, K. Pantya, P. Pales, E. R. Toke
This paper develops a peptide vaccine that mimics natural SARS-CoV-2 immunity and induces broad T cell responses in mice, validated across diverse human populations.
bioRxiv · Oct 16, 2020Immunology